GO:0051056 regulation of small GTPase mediated signal transduction: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051056 describes any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction, a central control node in eukaryotic cell biology.
• Small GTPases such as RAC1, RAP1, RAB5A and the Rag GTPases act as molecular switches whose regulation determines downstream signaling outcomes.
• The Rag-Ragulator complex is a key regulator of mTORC1 signaling and also licenses pyroptosis through gasdermin D and RIPK1-caspase-8 pathways.
• Dysregulation of small GTPase signaling is implicated in cancer, inflammatory and cardiovascular disease, and immune disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of GTPase regulatory networks.
• Combining CRISPR screening with bioinformatics and functional assays is a powerful strategy to identify regulators of small GTPase signaling.
Description
GO:0051056, regulation of small GTPase mediated signal transduction, is a biological process ontology term that captures any process modulating the frequency, rate or extent of signal transduction carried out by small GTPases. Small GTPases are conserved molecular switches that cycle between active GTP-bound and inactive GDP-bound states, and their regulation is essential for diverse cellular decisions including growth, cytoskeletal dynamics, membrane trafficking and immune signaling. Because these switches sit at the heart of many signaling circuits, understanding how they are regulated provides mechanistic insight into normal physiology and disease. The lysosomal Rag-Ragulator complex illustrates how a small GTPase regulatory module can coordinate nutrient sensing through mTORC1 while also controlling cell death and inflammatory outputs. Similarly, compartmentalized RAC1 signaling and Rap1-dependent endothelial responses demonstrate that spatial and temporal control of small GTPases is critical for cell behavior. RAB5A regulation of FSHR-mediated signal transduction in human granulosa cells further shows that small GTPase regulation operates in specialized endocrine contexts. In inflammation and atherogenesis, small GTPase regulation shapes immune cell recruitment and vascular pathology. For researchers, GO:0051056 therefore represents a unifying framework for studying how upstream regulators, guanine nucleotide exchange factors, GTPase-activating proteins and effector pathways converge on small GTPases. This article integrates authoritative ontology information with verified literature to outline the mechanisms, key genes, disease relevance and experimental models for studying regulation of small GTPase mediated signal transduction.
regulation of small GTPase mediated signal transduction At A Glance
| GO ID | GO:0051056 |
|---|---|
| GO term | regulation of small GTPase mediated signal transduction |
| Ontology | biological_process |
| Synonym | regulation of small GTPase-mediated signal transduction |
| Definition | Any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction. |
| Major function | Controls the timing, amplitude and location of small GTPase signaling outputs. |
| Example regulators | Rag-Ragulator complex, RAC1 compartmentalization machinery, Rap1 signaling components, RAB5A-associated pathways. |
| Disease relevance | Cancer, inflammatory and cardiovascular disease, immune disorders and endocrine signaling defects. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, screening and bioinformatics. |
What Is GO:0051056?
Regulation of small GTPase mediated signal transduction (GO:0051056) is defined as any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction. In practice, this includes mechanisms that control the activation state, localization, abundance or effector coupling of small GTPases, thereby tuning downstream signaling outputs. The term is a biological process and is not restricted to a single GTPase family; it encompasses regulation of Ras, Rho, Rab, Rap, Ran, Arf and Rag-family switches and their associated signaling pathways.
Why Is regulation of small GTPase mediated signal transduction Important in Cell Biology?
Regulation of small GTPase mediated signal transduction is important because small GTPases act as convergence points for growth factor, nutrient, immune and adhesion signals, and their dysregulation can reprogram cell growth, migration, secretion and death. The Rag-Ragulator complex links lysosomal nutrient sensing to mTORC1 and also controls pyroptotic cell death, showing that small GTPase regulation can determine whether a cell survives, grows or dies. RAC1 compartmentalization influences cytoskeletal and migratory programs relevant to cancer and development. Rap1 signaling in endothelial cells controls barrier function and angiogenesis. RAB5A participates in FSHR-mediated signal transduction in granulosa cells, highlighting roles in reproduction and endocrine signaling. Small GTPase regulation also shapes inflammation and atherogenesis, making it a therapeutic target area in cardiovascular disease. Consequently, researchers studying GO:0051056 need robust genetic models to determine causality and identify druggable nodes.
• Small GTPases are molecular switches whose regulation determines signaling amplitude and duration.
• The Rag-Ragulator complex regulates mTORC1 and pyroptosis, linking nutrient sensing to cell fate.
• RAC1 compartmentalization controls cytoskeletal dynamics and migration.
• Rap1 signaling regulates endothelial biology and vascular function.
• RAB5A modulates FSHR-mediated signal transduction in human granulosa cells.
• Small GTPase regulation contributes to inflammation and atherogenesis.
• Dysregulated small GTPase signaling is implicated in cancer and immune disorders.
• CRISPR models enable causal testing of GTPase regulatory mechanisms.
• Bioinformatics and screening approaches help identify novel regulators within GO:0051056.
• Understanding these mechanisms supports target discovery and therapeutic development.
What Happens During regulation of small GTPase mediated signal transduction?
GTPase activation and nucleotide cycling
In simple terms: Small GTPases act like switches that are turned on when they bind GTP and off when they bind GDP.
Small GTPases cycle between active GTP-bound and inactive GDP-bound states, and regulatory processes control the frequency and extent of this cycling to shape signal transduction. Guanine nucleotide exchange factors promote GTP loading, while GTPase-activating proteins accelerate GTP hydrolysis, and these activities are themselves regulated in space and time. The Rag GTPases within the Rag-Ragulator complex provide a structural example of how nucleotide state and complex assembly are coupled to downstream signaling.
Compartmentalization and spatial control
In simple terms: Where a GTPase is in the cell helps decide what it does.
Compartmentalization of RAC1 signaling demonstrates that small GTPase regulation is not uniform across the cell but is organized into distinct membrane domains that dictate effector engagement. Rap1 signaling in endothelial cells similarly depends on localized activation to control barrier and angiogenic responses. Lysosomal positioning of the Rag-Ragulator complex illustrates how organelle-specific scaffolds regulate mTORC1 signaling.
Effector coupling and downstream pathways
In simple terms: Once switched on, GTPases pass the signal to partner proteins that carry out the response.
Activated small GTPases bind effector proteins to propagate signals; for example, Rag-Ragulator-dependent regulation controls mTORC1 and TFEB, influencing growth and autophagy programs. The same regulatory module licenses gasdermin D oligomerization and pyroptosis, showing that effector coupling can determine inflammatory cell death outcomes. RIPK1 and caspase-8-mediated pyroptosis by Yersinia also depends on the lysosomal Rag-Ragulator complex, linking bacterial sensing to small GTPase regulation.
Integration with immune and inflammatory signaling
In simple terms: GTPase regulation helps immune cells decide when to respond and when to die.
Small GTPase regulation shapes inflammation and atherogenesis by controlling immune cell activation, recruitment and vascular responses. NK cell receptor signaling studies provide early context for how GTPase-dependent pathways influence immune recognition and cytotoxicity. The Rag-Ragulator control of pyroptosis further demonstrates that small GTPase regulatory nodes are central to inflammatory cell death.
Tissue-specific and endocrine contexts
In simple terms: Different tissues use GTPase regulation for specialized jobs.
RAB5A regulates FSHR-mediated signal transduction in human granulosa cells, indicating that small GTPase regulation operates in endocrine signaling and reproductive biology. Rap1 in endothelial biology shows vascular-specific functions. These examples illustrate that GO:0051056 encompasses context-dependent regulatory mechanisms rather than a single universal pathway.
Key Genes Involved in GO:0051056 regulation of small GTPase mediated signal transduction
The following genes and protein complexes are representative regulators or mediators within regulation of small GTPase mediated signal transduction (GO:0051056), based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RagA/RagB (RRAGA/RRAGB) | Rag GTPases in the Rag-Ragulator complex regulating mTORC1 | Nutrient sensing, lysosomal signaling and pyroptosis models |
| RagC/RagD (RRAGC/RRAGD) | Rag GTPase partners in Ragulator complex | Structural and functional studies of mTORC1-TFEB regulation |
| LAMTOR1-5 | Ragulator scaffold components | Anchor Rag GTPases to lysosomes and regulate mTORC1 |
| RAC1 | Rho-family GTPase controlling cytoskeleton and migration | Compartmentalized signaling studies in cancer and development |
| RAP1 (RAP1A/RAP1B) | Ras-family GTPase in endothelial signaling | Vascular barrier and angiogenesis research |
| RAB5A | Rab-family GTPase in endosomal signaling | FSHR-mediated signal transduction in granulosa cells |
| mTOR | Kinase downstream of Rag-Ragulator | Growth, autophagy and TFEB regulation |
| TFEB | Transcription factor controlled by mTORC1 | Lysosomal biogenesis and autophagy studies |
| GSDMD | Gasdermin D pore-forming protein | Pyroptosis regulation by Rag-Ragulator-mTORC1 |
| RIPK1 | Kinase in cell death signaling | Yersinia-induced pyroptosis requiring Rag-Ragulator |
| CASP8 | Caspase-8 in extrinsic apoptosis/pyroptosis | Rag-Ragulator-dependent cell death |
| FSHR | Follicle-stimulating hormone receptor | RAB5A-dependent signal transduction in granulosa cells |
| NK cell receptors | Immune recognition receptors | Early context for GTPase-linked immune signaling |
| Rho-family regulators | GEFs and GAPs controlling GTPase cycling | Mechanistic studies of small GTPase regulation |
| Ras-family regulators | GEFs and GAPs for Rap and Ras | Endothelial and inflammatory signaling |
| Rab-family regulators | GEFs, GAPs and effectors for Rab GTPases | Endosomal and endocrine signaling |
| Inflammatory signaling mediators | Cytokines and adhesion molecules | Atherogenesis and inflammation models |
How Is regulation of small GTPase mediated signal transduction Regulated?
Regulation of small GTPase mediated signal transduction is itself controlled by multi-protein complexes and upstream cues. The Rag-Ragulator complex integrates nutrient and lysosomal signals to control mTORC1, which in turn phosphorylates TFEB and other substrates. This same complex regulates gasdermin D oligomerization and pyroptosis, indicating that cell death and inflammatory outputs are coupled to GTPase regulatory state. Yersinia infection triggers RIPK1 and caspase-8-mediated pyroptosis in a manner that requires the lysosomal Rag-Ragulator complex, showing pathogen-responsive control. Compartmentalization further refines RAC1 signaling, allowing localized regulation rather than global activation. Rap1 signaling in endothelial cells is tuned by adhesion and growth factor inputs. RAB5A-dependent FSHR signaling in granulosa cells illustrates hormone-driven regulation. In inflammation and atherogenesis, small GTPase regulation is influenced by lipid and cytokine environments.
regulation of small GTPase mediated signal transduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAC1 | Cancer cell migration and invasion | Knockout and point-mutation cell lines with migration assays |
| RAP1A/RAP1B | Endothelial barrier dysfunction and vascular disease | Endothelial knockout and overexpression models |
| RAB5A | Endocrine signaling defects in granulosa cells | Knockout and knock-in granulosa cell models |
| RRAGA/RRAGB | mTORC1-related growth and inflammatory disease | Knockout and point-mutation models for mTORC1 and pyroptosis |
| GSDMD | Pyroptosis and inflammatory disease | Knockout and overexpression models with inflammasome activation |
Cancer and metastatic signaling
Small GTPase regulation controls cytoskeletal dynamics, migration and proliferation, and compartmentalized RAC1 signaling is particularly relevant to cancer cell behavior. Dysregulated GTPase pathways can promote invasive and metastatic phenotypes, making regulators within GO:0051056 candidate therapeutic targets.
Inflammatory and cardiovascular disease
Small GTPase regulation shapes inflammation and atherogenesis, influencing immune cell recruitment and vascular pathology. The Rag-Ragulator control of pyroptosis links nutrient sensing to inflammatory cell death, which is relevant to infection and inflammatory disease.
Immune disorders and host defense
NK cell receptor signaling and GTPase-dependent immune pathways influence recognition and cytotoxicity. Yersinia-induced pyroptosis requiring Rag-Ragulator demonstrates how pathogens intersect with small GTPase regulatory modules.
Endocrine and reproductive biology
RAB5A regulation of FSHR-mediated signal transduction in human granulosa cells indicates that small GTPase regulation is important for endocrine signaling and ovarian function. Rap1 signaling in endothelial biology also affects vascular contributions to reproductive and systemic physiology.
From regulation of small GTPase mediated signal transduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a GTPase regulator required for mTORC1 signaling? | CRISPR knockout of Rag-Ragulator components followed by mTORC1 readouts |
| Does a GTPase regulatory node control pyroptosis? | Knockout and point-mutation models with gasdermin D and caspase-8 assays |
| How does RAC1 compartmentalization affect migration? | Tagged knock-in and knockout cell lines with imaging and migration assays |
| What is the role of RAB5A in FSHR signaling? | Knockout and overexpression granulosa cell models with hormone stimulation |
| Which regulators modulate Rap1 in endothelium? | Endothelial knockout, knock-in and overexpression models |
| Can a candidate regulator be validated causally? | CRISPR screening plus targeted knockout and rescue |
How to Study the regulation of small GTPase mediated signal transduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Testing requirement of GTPase regulators |
| Point mutation | Specific residue function | Dissecting nucleotide or effector interfaces |
| Knock-in / tagged knock-in | Localization and complex assembly | Imaging compartmentalized signaling |
| Overexpression | Sufficiency and gain-of-function | Rescue and pathway activation studies |
| CRISPR library screening | Genome-wide regulator discovery | Identifying modulators of GTPase signaling |
| Proteomics | Protein interactions and complexes | Mapping Rag-Ragulator and effector networks |
| Imaging | Spatial and temporal dynamics | Studying RAC1 and Rap1 compartmentalization |
| Bioinformatics | Pathway and network enrichment | Prioritizing candidate regulators |
CRISPR knockout and point-mutation models
CRISPR knockout and point-mutation approaches allow precise testing of whether a GTPase or regulator is required for signaling outputs such as mTORC1 activity, TFEB localization or pyroptosis. Point mutations can dissect nucleotide-binding or effector-coupling residues without eliminating protein expression.
Knock-in and tagged knock-in reporters
Knock-in of tags or reporters enables visualization of GTPase localization and complex assembly, which is essential for studying compartmentalized signaling such as RAC1 and Rap1. Tagged knock-in models also support biochemical isolation of regulatory complexes.
Overexpression and rescue experiments
Overexpression of wild-type or mutant GTPases and regulators can test sufficiency, while rescue of knockout phenotypes confirms specificity. These approaches are useful for validating RAB5A-dependent FSHR signaling and Rag-Ragulator-dependent pyroptosis.
Screening, proteomics and bioinformatics
CRISPR library screening combined with proteomics and bioinformatics can identify novel regulators within GO:0051056 and prioritize candidates for mechanistic follow-up. Pathway enrichment and network analysis help place hits into small GTPase signaling modules.
How CRISPR Can Be Used to Study GO:0051056 regulation of small GTPase mediated signal transduction
Knockout
CRISPR knockout of small GTPases or their regulators is used to determine necessity in signaling pathways such as mTORC1 regulation and pyroptosis. Knockout models also help define which components of GO:0051056 are non-redundant in a given cell type.
Point Mutation
Point mutation models allow precise interrogation of GTP binding, hydrolysis or effector coupling without deleting the gene, which is valuable for dissecting Rag GTPase function and RAC1 signaling. These models can separate activation-state effects from scaffolding functions.
Knock-in
Knock-in of tags, reporters or disease-associated variants enables tracking of GTPase localization and complex formation in live cells, supporting studies of compartmentalized RAC1 and Rap1 signaling. Knock-in also facilitates biochemical purification of regulatory complexes.
Overexpression
Overexpression of wild-type or mutant GTPases and regulators tests sufficiency and can rescue knockout phenotypes, as shown for RAB5A-dependent FSHR signaling and Rag-Ragulator-dependent pyroptosis. Overexpression is also useful for screening downstream effector responses.
How EDITGENE Supports regulation of small GTPase mediated signal transduction Research
Researchers studying regulation of small GTPase mediated signal transduction-related genes often need to determine whether a candidate gene is causally involved in a signaling phenotype, which requires precise genetic models rather than correlative observations. EDITGENE provides end-to-end CRISPR services to generate such models and to support mechanistic and translational studies of GO:0051056.
Contact EDITGENE today to design your custom CRISPR model for regulation of small GTPase mediated signal transduction research.
Frequently Asked Questions About regulation of small GTPase mediated signal transduction
What is GO:0051056 regulation of small GTPase mediated signal transduction?
GO:0051056 is a biological process term defined as any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction.
What genes are involved in regulation of small GTPase mediated signal transduction?
Representative genes include RRAGA/RRAGB, RRAGC/RRAGD, LAMTOR1-5, RAC1, RAP1A/RAP1B, RAB5A, mTOR, TFEB, GSDMD, RIPK1 and CASP8.
Why is small GTPase regulation important in disease?
Dysregulated small GTPase signaling contributes to cancer, inflammatory and cardiovascular disease, immune disorders and endocrine signaling defects.
How does the Rag-Ragulator complex regulate signaling?
The Rag-Ragulator complex controls mTORC1 and TFEB and also licenses gasdermin D and RIPK1-caspase-8-mediated pyroptosis.
What is the role of RAC1 compartmentalization?
Compartmentalization of RAC1 signaling organizes localized effector engagement that controls cytoskeletal dynamics and migration.
How is RAB5A involved in FSHR signaling?
RAB5A regulates FSHR-mediated signal transduction in human granulosa cells, linking small GTPase regulation to endocrine signaling.
What methods are used to study GO:0051056?
CRISPR knockout, point mutation, knock-in, overexpression, screening, proteomics, imaging and bioinformatics are commonly used.
Can CRISPR screens identify new GTPase regulators?
Yes, CRISPR library screening combined with bioinformatics can discover and prioritize novel regulators of small GTPase signaling.
What cell models are suitable for pyroptosis studies?
Knockout and point-mutation models of Rag-Ragulator components and GSDMD are suitable for pyroptosis studies.
How does Rap1 regulate endothelial biology?
Rap1 signaling in endothelial cells controls barrier function and angiogenic responses.
Conclusion
GO:0051056 regulation of small GTPase mediated signal transduction is a broad but mechanistically coherent biological process that governs how small GTPases convert upstream cues into downstream cellular outcomes. The Rag-Ragulator-mTORC1 axis, RAC1 compartmentalization, Rap1 endothelial signaling and RAB5A-dependent FSHR signaling illustrate the diversity of regulatory mechanisms within this term. Because these pathways influence cancer, inflammation, cardiovascular disease and endocrine function, precise genetic models are essential for causal discovery. CRISPR-based knockout, point-mutation, knock-in and overexpression approaches, combined with screening and bioinformatics, provide a robust toolkit for dissecting GO:0051056 in health and disease.
References
- 1. Cui Z et al.. 2023. Structure of the lysosomal mTORC1-TFEB-Rag-Ragulator megacomplex.. Nature 614(7948):572-579 PMID: 36697823
- 2. Evavold CL et al.. 2021. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway.. Cell 184(17):4495-4511.e19 PMID: 34289345
- 3. Zheng Z et al.. 2021. The Lysosomal Rag-Ragulator Complex Licenses RIPK1 and Caspase-8-mediated Pyroptosis by Yersinia.. Science 372(6549) PMID: 35058659
- 4. Payapilly A et al.. 2018. Compartmentalisation of RAC1 signalling.. Curr Opin Cell Biol 54:50-56 PMID: 29723737
- 5. Lanier LL. 1998. NK cell receptors.. Annu Rev Immunol 16:359-93 PMID: 9597134
- 6. Chrzanowska-Wodnicka M. 2017. Rap1 in endothelial biology.. Curr Opin Hematol 24(3):248-255 PMID: 28178039
- 7. Zhu K et al.. 2018. Role of RAB5A in FSHR-mediated signal transduction in human granulosa cells.. Reproduction 155(6):505-514 PMID: 29626103
- 8. Lu Y et al.. 2013. Small GTPase and regulation of inflammation response in atherogenesis.. J Cardiovasc Pharmacol 62(4):331-40 PMID: 23921305
